Factors Associated with Time Intervals for Diagnosis of Colorectal Cancer: A Hospital Based Study in Khon Kaen, Thailand.
Adult
Aged
Aged, 80 and over
Colorectal Neoplasms
/ diagnosis
Cross-Sectional Studies
Delayed Diagnosis
/ trends
Female
Follow-Up Studies
Health Services Accessibility
/ statistics & numerical data
Hospitals
/ statistics & numerical data
Humans
Male
Middle Aged
Prognosis
Registries
/ statistics & numerical data
Thailand
/ epidemiology
Time Factors
Young Adult
Time intervals
colorectal cancer
delay diagnosis
Journal
Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625
Informations de publication
Date de publication:
01 Jun 2020
01 Jun 2020
Historique:
received:
06
02
2020
entrez:
28
6
2020
pubmed:
28
6
2020
medline:
12
2
2021
Statut:
epublish
Résumé
Colorectal cancer (CRC) is among the five-leading cancers in Thailand. Delayed diagnosis is crucial for undermining the prognosis of the patients. This study aims to evaluate the factors associated with the time interval for diagnosis (TID). A cross-sectional analytical study of 191 CRC patients with histological confirmation who were undergoing treatment in the tertiary hospital in Khon Kaen Province was conducted. The data were obtained by interview and retrieving from medical records. The time interval in each diagnostic process is reported in geometric mean. The geometric mean ratio (GMR) used to interpret the results from multiple linear regressions that analyze the relationship between factors and log-transformed TID. Most patients were males (61.78%) with mean age of 61.28±10.2 years old. The geometric mean of TID was 263.48 days. Two factors were significantly associated with longer TID: first visit at a tertiary hospital (GMR=7.77 relative to secondary hospital; 95%CI=1.95 to 30.57) and distance to tertiary healthcare. Two factors were significantly associated with shorter TID: officer/ state enterprise (GMR=0.53 relative to agriculture; 95%CI=0.28 to 0.98) and cost of traveling to secondary healthcare. The results showed the occupation, first health care visit, distance and cost were factors associated with TID. Improving the facilities at the secondary healthcare units for diagnosing CRC would be likely to help to reduce the wasted time in the healthcare system.
Sections du résumé
BACKGROUND
BACKGROUND
Colorectal cancer (CRC) is among the five-leading cancers in Thailand. Delayed diagnosis is crucial for undermining the prognosis of the patients. This study aims to evaluate the factors associated with the time interval for diagnosis (TID).
METHODS
METHODS
A cross-sectional analytical study of 191 CRC patients with histological confirmation who were undergoing treatment in the tertiary hospital in Khon Kaen Province was conducted. The data were obtained by interview and retrieving from medical records. The time interval in each diagnostic process is reported in geometric mean. The geometric mean ratio (GMR) used to interpret the results from multiple linear regressions that analyze the relationship between factors and log-transformed TID.
RESULTS
RESULTS
Most patients were males (61.78%) with mean age of 61.28±10.2 years old. The geometric mean of TID was 263.48 days. Two factors were significantly associated with longer TID: first visit at a tertiary hospital (GMR=7.77 relative to secondary hospital; 95%CI=1.95 to 30.57) and distance to tertiary healthcare. Two factors were significantly associated with shorter TID: officer/ state enterprise (GMR=0.53 relative to agriculture; 95%CI=0.28 to 0.98) and cost of traveling to secondary healthcare.
CONCLUSIONS
CONCLUSIONS
The results showed the occupation, first health care visit, distance and cost were factors associated with TID. Improving the facilities at the secondary healthcare units for diagnosing CRC would be likely to help to reduce the wasted time in the healthcare system.
Identifiants
pubmed: 32592385
doi: 10.31557/APJCP.2020.21.6.1835
pmc: PMC7568870
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1835-1840Références
Am J Health Behav. 2015 Jan;39(1):22-33
pubmed: 25290594
Can J Gastroenterol. 2010 Jan;24(1):33-9
pubmed: 20186354
BMC Public Health. 2019 Feb 18;19(1):204
pubmed: 30777038
J Clin Epidemiol. 2012 Jun;65(6):669-78
pubmed: 22459430
BMC Cancer. 2013 Feb 23;13:87
pubmed: 23432789
BMC Health Serv Res. 2008 Feb 28;8:49
pubmed: 18307790
Asian Pac J Cancer Prev. 2015;16(12):4901-3
pubmed: 26163612
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
Oncologist. 2007 Jul;12(7):816-24
pubmed: 17673613
Br J Cancer. 2009 Dec 3;101 Suppl 2:S5-8
pubmed: 19956163
Br J Cancer. 2016 Aug 23;115(5):533-41
pubmed: 27490803
BMC Health Serv Res. 2017 Jan 5;17(1):7
pubmed: 28056946
J Epidemiol. 2014;24(2):102-8
pubmed: 24335087
Kathmandu Univ Med J (KUMJ). 2012 Apr-Jun;10(38):63-70
pubmed: 23132479
Cancer Res Treat. 2018 Oct;50(4):1270-1280
pubmed: 29334608
Psychooncology. 2017 Jan;26(1):29-36
pubmed: 26868950
Can Fam Physician. 2015 Nov;61(11):e509-16
pubmed: 26889506
Br J Cancer. 2009 Dec 3;101 Suppl 2:S92-S101
pubmed: 19956172
Med Care. 2000 Jan;38(1):108-14
pubmed: 10630725
Pneumonol Alergol Pol. 2012;80(5):422-9
pubmed: 22926903
Br J Gen Pract. 2017 Jul;67(660):e460-e466
pubmed: 28583943
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Eur J Cancer. 2017 Dec;87:113-121
pubmed: 29145037
BMC Public Health. 2019 Jul 29;19(1):1016
pubmed: 31357981
N Z Med J. 2018 Oct 5;131(1483):30-39
pubmed: 30286063
J Formos Med Assoc. 2014 Oct;113(10):696-703
pubmed: 25240303
Br J Cancer. 2014 Jul 29;111(3):581-8
pubmed: 24918824
Health Serv Res Manag Epidemiol. 2016 May 9;3:2333392816646670
pubmed: 28462276
Patient Educ Couns. 2011 Sep;84(3):352-8
pubmed: 21621950
Clin Breast Cancer. 2018 Jun;18(3):239-245
pubmed: 29033239
Br J Cancer. 2011 Mar 15;104(6):934-40
pubmed: 21364593
Oncotarget. 2016 Aug 9;7(32):52095-52103
pubmed: 27437765
BMC Res Notes. 2012 Aug 21;5:452
pubmed: 22909280
Br J Cancer. 2005 Jun 6;92(11):1959-70
pubmed: 15870714
J Cancer Educ. 2019 Jun;34(3):423-434
pubmed: 28782080
J Clin Oncol. 2014 Mar 20;32(9):942-8
pubmed: 24516014